flumazenil has been researched along with tert-butyl beta-carboline-3-carboxylate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
| Clayton, T; Cook, J; DeLorey, TM; Furtmüller, R; Halliwell, RF; Harris, D; Huck, S; Sahbaie, P; Sieghart, W | 1 |
| Clayton, T; Cook, JM; Cromer, BA; Ma, C; Majumder, S; Namjoshi, OA; Petrou, S; Platt, DM; Roth, BL; VanLinn, ML; Yin, W | 1 |
| Cook, JM; Hagen, T; Katz, JL; Suzuki, T; Takada, K | 1 |
| Bergman, J; Paronis, CA | 1 |
| Avenet, P; Granger, P; Griebel, G; Letang, V; Perrault, G; Sanger, DJ; Schoemaker, H | 1 |
| Cook, JM; Ma, C; Miczek, KA; Rowlett, JK; Tornatzky, W | 1 |
| Bergman, J; Cook, JM; Cox, ED; Paronis, CA | 1 |
| Cook, JM; DeLorey, TM; He, X; Lameh, J; Lin, RC; Loew, GH; McBrady, B | 1 |
| Carter, L; Cook, JM; France, CP; Gerak, LR; Ma, C; McMahon, LR | 1 |
| Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Bokonjić, DR; Cook, JM; Obradović, DI; Savić, MM; Ugresić, ND; Yin, W | 2 |
| Bokonjić, DR; Cook, JM; Obradović, DI; Sarma, PV; Savić, MM; Ugresić, ND | 1 |
| Cook, JB; Cook, JM; Eiler, WJ; Foster, KL; Goergen, J; Homanics, GE; Johnson, N; June, HL; Mensah-Zoe, B; Simmons, JO; Yin, W | 1 |
| Atack, JR; Cook, JM; Dawson, GR; Licata, SC; Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Van Linn, ML | 1 |
| Cook, JM; Divljaković, J; Milić, M; Rallapalli, S; Savić, MM; Timić, T; van Linn, ML | 1 |
| Cook, JM; Divljaković, J; Milić, M; Namjoshi, OA; Savić, MM; Timić, T; Tiruveedhula, VV | 1 |
18 other study(ies) available for flumazenil and tert-butyl beta-carboline-3-carboxylate
| Article | Year |
|---|---|
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
Topics: Animals; Behavior, Animal; Benzodiazepines; Chemical Phenomena; Chemistry, Physical; Computer Simulation; Databases, Factual; Electrophysiology; Female; Ligands; Male; Memory; Mice; Models, Molecular; Molecular Structure; Oocytes; Protein Isoforms; Protein Subunits; Quantitative Structure-Activity Relationship; Receptors, GABA-A; Structure-Activity Relationship; Xenopus laevis | 2008 |
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Topics: Alcoholism; Animals; Benzodiazepines; Binding Sites; Carbolines; Cell Line; Computer Simulation; GABA-A Receptor Antagonists; Humans; Protein Subunits; Rats; Receptors, GABA-A; Stereoisomerism; Structure-Activity Relationship | 2010 |
Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats.
Topics: Animals; Behavior, Animal; Benzodiazepines; Carbolines; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Tolerance; Flumazenil; Male; Pyrazoles; Rats; Rats, Inbred F344 | 1989 |
Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Binding, Competitive; Carbolines; Dose-Response Relationship, Drug; Electroshock; Feeding Behavior; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Kinetics; Male; Midazolam; Receptors, GABA-A; Reinforcement Schedule; Saimiri | 1999 |
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepines; Binding, Competitive; Carbolines; Diazepam; Flumazenil; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Ligands; Male; Mice; Mice, Inbred BALB C; Motor Activity; Muscle Relaxants, Central; Patch-Clamp Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 1999 |
Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Body Temperature; Carbolines; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Antagonists; Mice; Pyridines; Receptors, GABA-A; Triazolam; Vocalization, Animal; Zolpidem | 2001 |
Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys.
Topics: Acetamides; Animals; Carbolines; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Midazolam; Pyridines; Pyrimidines; Reaction Time; Receptors, GABA-A; Saimiri; Zolpidem | 2001 |
Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory.
Topics: Animals; Azides; Benzodiazepines; Binding Sites; Binding, Competitive; Carbolines; Conditioning, Psychological; Convulsants; Fear; Flumazenil; GABA Antagonists; GABA Modulators; Imidazoles; Ligands; Male; Memory; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylscopolamine; Piperazines; Quinolines; Receptors, GABA-A; Scopolamine; Silanes; Tritium | 2001 |
Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
Topics: Acetamides; Animals; Carbolines; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Agonists; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Ligands; Macaca mulatta; Midazolam; Pyridines; Pyrimidines; Receptors, GABA-A; Zolpidem | 2002 |
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Antagonists; Male; Motor Activity; Pyridines; Receptors, GABA-A; Saimiri; Social Behavior; Triazolam; Zolpidem | 2002 |
Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding Sites; Carbolines; Drug Interactions; Flumazenil; GABA Modulators; Ligands; Male; Maze Learning; Mice; Midazolam; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 2004 |
Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Avoidance Learning; Binding Sites; Carbolines; Dose-Response Relationship, Drug; Electroshock; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Ligands; Male; Memory; Midazolam; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, GABA-A | 2005 |
Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepines; Binding Sites; Carbolines; Convulsants; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Habituation, Psychophysiologic; Injections, Intraperitoneal; Ligands; Male; Midazolam; Motor Activity; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Retention, Psychology; Zolpidem | 2005 |
Dopamine and benzodiazepine-dependent mechanisms regulate the EtOH-enhanced locomotor stimulation in the GABAA alpha1 subunit null mutant mice.
Topics: Animals; Behavior, Animal; Benzazepines; Benzodiazepines; Carbolines; Central Nervous System Depressants; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Flumazenil; GABA Modulators; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Receptors, GABA-A; Reinforcement, Psychology; Salicylamides; Self Administration | 2007 |
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.
Topics: Animals; Barbiturates; Carbolines; Catheterization; Central Nervous System Depressants; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethanol; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Antagonists; GABA Modulators; Neuropsychological Tests; Pyridines; Receptors, GABA-A; Saimiri; Triazoles; Zolpidem | 2010 |
The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.
Topics: Animals; Ataxia; Benzodiazepines; Benzodiazepinones; Carbolines; Diazepam; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hand Strength; Imidazoles; Male; Muscle Relaxation; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Rotarod Performance Test; Zolpidem | 2012 |
βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.
Topics: Animals; Anxiety; Carbolines; Diazepam; Flumazenil; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Male; Maze Learning; Rats; Rats, Wistar; Receptors, GABA-A; Substance Withdrawal Syndrome | 2013 |